Full Year 2024 Pro Medicus Ltd Earnings Call Transcript
Key Points
- Revenue increased by 29.3% and profit after tax rose by 36.5%, indicating strong financial performance.
- Nine new contract wins in North America, all cloud-based, showcasing successful market penetration.
- Continued investment in AI and other ologies, positioning the company for future growth.
- Record year in terms of new sales and successful implementations, setting a strong base for FY25.
- High client retention rate with 100% renewal, demonstrating customer satisfaction and loyalty.
- Ongoing radiologist shortage and burnout issues, which could impact service delivery.
- High dependency on the US market, which may pose risks if market conditions change.
- Some delays in contract implementations, such as the Baylor Scott & White contract.
- Increased operational costs, including a 26% rise in employee benefits, which could impact margins.
- Challenges in penetrating the private radiology market due to price sensitivity.
Thank you. Good morning everybody and thanks for joining us for our full-year results presentation. As most of you know we're a healthcare IT company specializing in enterprise imaging and radiology informatics systems. We work in three jurisdictions: Melbourne, Australia, our corporate office and where we do the development and sales for our RIS product; Berlin which is our R&D center and one support center for the Visage product; and US which is our main market.
We are heavily technically focused. Nearly half our staff are either programmers or technical support. The second biggest group of staff are clinical support because as you know ours is a clinical product. So very much client-focused staff mix.
In terms of our results, we believe all of our key metrics moved in the right direction. Obviously, revenue was up 29.3%; and profit after tax, 36.5%. I think underlying EBIT was also up, as were our margins. And I think, pleasingly, we continued to accrue cash even after paying dividends
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |